FG
MLAB icon

Fairman Group’s Mesa Laboratories MLAB Stock Holding History

Fairman Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8
Closed -$1.04K – 381
2024
Q3 		$1.04K Hold
8
– – ﹤0.01% 334
2024
Q2 		$694 Hold
8
– – ﹤0.01% 347
2024
Q1 		$878 Hold
8
– – ﹤0.01% 332
2023
Q4 		$838 Buy
+8
New +$780 ﹤0.01% 329

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fairman Group's MLAB Position: Q4 2024 in Review

Fairman Group sold out of Mesa Laboratories (MLAB) in Q4 2024, closing a stake of 8 shares — an estimated $1.04K sold.

Fairman Group first reported a position in MLAB in Q4 2023 and held it in 4 quarters. The position peaked at $1.04K in Q3 2024. 156 funds tracked by Wall St. Rank hold MLAB as of Q4 2024.

  • Fairman Group reported no remaining Mesa Laboratories position as of Q4 2024 after selling out during the quarter.
  • Fairman Group sold 8 Mesa Laboratories shares in Q4 2024, an estimated $1.04K.
  • Fairman Group first reported a position in Mesa Laboratories in Q4 2023 and held it in 4 quarters.
  • Fairman Group's Mesa Laboratories position peaked at $1.04K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2024.

Based on Fairman Group's 13F filing for Q4 2024, filed 29 Jan 2025.